Detalles de la búsqueda
1.
Benefits of Structured Pediatric to Adult Transition in Inflammatory Bowel Disease: The TRANSIT Observational Study.
J Pediatr Gastroenterol Nutr
; 74(2): 208-214, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34694262
2.
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.
Gut
; 69(6): 984-990, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303607
3.
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel.
Gut
; 69(10): 1769-1777, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32513653
4.
Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.
Gastroenterology
; 156(5): 1354-1367.e6, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30550821
5.
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
Gut
; 68(Suppl 3): s1-s106, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562236
6.
Can molecular stratification improve the treatment of inflammatory bowel disease?
Pharmacol Res
; 148: 104442, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31491469
7.
A multicentre Study of Nutrition Risk Assessment in Adult Patients with Inflammatory Bowel Disease Attending Outpatient Clinics.
Ann Nutr Metab
; 74(1): 18-23, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30485836
8.
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.
JAMA
; 321(8): 773-785, 2019 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30806694
9.
UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care.
Gut
; 66(6): 988-1000, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28228488
10.
Dietary treatment of Crohn's disease: perceptions of families with children treated by exclusive enteral nutrition, a questionnaire survey.
BMC Gastroenterol
; 17(1): 14, 2017 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-28103809
11.
Reply.
Gastroenterology
; 157(4): 1161-1162, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31408620
12.
Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding.
J Hepatol
; 61(5): 1014-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24953021
13.
Delivering optimal care for inflammatory bowel disease patients in Scotland in 2014.
Scott Med J
; 59(2): 130-5, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24728818
14.
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUST.
Aliment Pharmacol Ther
; 59(2): 175-185, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38036946
15.
The evolution of ScotRIGHT: The first pan-Scotland physician trainee research network.
J R Coll Physicians Edinb
; 53(4): 302-306, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650310
16.
Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn's disease: Results up to Week 104 of the STARDUST trial.
United European Gastroenterol J
; 11(5): 410-422, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37139642
17.
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom.
Inflamm Bowel Dis
; 2023 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37603730
18.
Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding-long-term follow-up of a randomised control trial.
Aliment Pharmacol Ther
; 55(12): 1581-1587, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35322892
19.
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial.
Lancet Gastroenterol Hepatol
; 7(4): 294-306, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35120656
20.
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study.
Aliment Pharmacol Ther
; 56(8): 1250-1263, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36039036